. Author manuscript; available in PMC: 2020 Jun 30.

Published in final edited form as: Mult Scler Relat Disord. 2019 Feb 11;30:136–140. doi: 10.1016/j.msard.2019.02.013

Table 3.

Adverse events

Possibly related to study drug
Event	No. of participants (%)
Transient paresthesias in groin and lower extremities	5 (62.5)
Transient increase in lower extremity spasticity	1 (12.5)
Transient lower extremity weakness	1 (12.5)
Worsened fatigue	2 (25)
Fever and rigors	1 (12.5)
Unrelated to study drug
Event	No. of participants (%)
Post-lumbar puncture headache	2 (25)
Disorientation and drowsiness^#	1 (12.5)

Following administration of lorazepam for transient worsening of lower extremity spasticity